Galera Therapeutics, Inc. Common Stock
GRTX
GRTX was delisted on the 3rd of June, 2024.
32 hedge funds and large institutions have $224M invested in Galera Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 32 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$53.2M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$41.6M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$37.6M |
| 4 |
Blackstone Inc
New York
|
+$20.5M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$15.9M |
Top Sellers
GRTX Hedge Fund Activity: Q4 2019 in Review
32 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Galera Therapeutics, Inc. Common Stock (GRTX) for Q4 2019, worth a combined $224M.
Buyers outnumbered sellers: 32 funds opened new GRTX positions and 0 closed out — a net gain of 32 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was NEA Management Company, opening a new position worth an estimated $53.2M.
- 32 institutional investors held Galera Therapeutics, Inc. Common Stock (GRTX) as of Q4 2019, up from 0 in Q3 2019.
- Funds reported $224M of Galera Therapeutics, Inc. Common Stock stock for Q4 2019.
- 32 funds opened new Galera Therapeutics, Inc. Common Stock positions in Q4 2019 and 0 closed out, a net change of +32 holders.
- The largest Galera Therapeutics, Inc. Common Stock buyer in Q4 2019 was NEA Management Company, an estimated $53.2M added.
Based on aggregated 13F filings for Q4 2019.